Cargando…
Immunity to live: an immunopathoscore using the consensus Immunoscore to best define the risk of recurrence and death in stage IV metastatic patients
The consensus Immunoscore is a routine assay quantifying the adaptive immune response within the tumor microenvironment. Its evaluation in the primary tumor of patients with stages I/II/III colorectal cancer (CRC) has prognostic value that has been confirmed in multiple studies. For metastatic patie...
Autores principales: | Baldin, Pamela, Van den Eynde, Marc, Mlecnik, Bernhard, Galon, Jérôme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561331/ https://www.ncbi.nlm.nih.gov/pubmed/33110705 http://dx.doi.org/10.1080/2162402X.2020.1826133 |
Ejemplares similares
-
Multiverse of immune microenvironment in metastatic colorectal cancer
por: Van den Eynde, Marc, et al.
Publicado: (2020) -
The consensus immunoscore: toward a new classification of colorectal cancer
por: Lanzi, Anastasia, et al.
Publicado: (2020) -
The consensus Immunoscore in phase 3 clinical trials; potential impact on patient management decisions
por: Pagès, Franck, et al.
Publicado: (2020) -
The consensus Immunoscore in phase 3 clinical trial (N0147) and impact on patient management decisions
por: Lanzi, Anastasia, et al.
Publicado: (2020) -
Metastasis immune-based scores predict patient survival
por: Mlecnik, Bernhard, et al.
Publicado: (2020)